Clinical Trial Update: Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the safety and efficacy of combining an immune checkpoint inhibitor with radiochemotherapy in locally advanced head and neck can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Kuwait Cancer Control Center | Conditions: Locally Advanced Head and Neck Cancer | Phase 2 | Status: UNKNOWN